TY - JOUR
T1 - Age-related differences in the use of morphine, diazepam, and pancuronium for mechanically ventilated children
AU - Mickell, J. J.
AU - Pedigo, S. A.
AU - Lucking, S. E.
AU - Albert, M. A.
PY - 1990
Y1 - 1990
N2 - Mechanically ventilated children usually require a combination of sedation (morphine = M, diazepam = D) and paralysis (pancuronium = P) to minimize anxiety, discomfort, and the risks of self-extubation, tracheal injury, and pulmonary barotrauma. We sought to determine whether our use of MDP varied with patient age. Cases where the dosage of MDP would be infuenced by neurological, hemodynamic, or painful diagnoses were excluded. The 36 cases selected were divided according to age into three groups (< 4 months = A, 4-18 months = B, > 18 months = C). The daily sum of MDP dosages was calculated for each of the 326 study days, a mean of 9 study days for each case. The median daily drug usage in group B (2.3 mg/kg/day) was twice that in either group A (younger) or group C (older) (both p < 0.001). This finding may be explained by developmental changes in physiology, pharmacology, and behavior, and may have been influenced by a paradoxical drug effect or multiple drug antagonism.
AB - Mechanically ventilated children usually require a combination of sedation (morphine = M, diazepam = D) and paralysis (pancuronium = P) to minimize anxiety, discomfort, and the risks of self-extubation, tracheal injury, and pulmonary barotrauma. We sought to determine whether our use of MDP varied with patient age. Cases where the dosage of MDP would be infuenced by neurological, hemodynamic, or painful diagnoses were excluded. The 36 cases selected were divided according to age into three groups (< 4 months = A, 4-18 months = B, > 18 months = C). The daily sum of MDP dosages was calculated for each of the 326 study days, a mean of 9 study days for each case. The median daily drug usage in group B (2.3 mg/kg/day) was twice that in either group A (younger) or group C (older) (both p < 0.001). This finding may be explained by developmental changes in physiology, pharmacology, and behavior, and may have been influenced by a paradoxical drug effect or multiple drug antagonism.
UR - http://www.scopus.com/inward/record.url?scp=0025023617&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025023617&partnerID=8YFLogxK
U2 - 10.1159/000480935
DO - 10.1159/000480935
M3 - Article
C2 - 2311477
AN - SCOPUS:0025023617
SN - 0379-8305
VL - 14
SP - 20
EP - 28
JO - Developmental Pharmacology and Therapeutics
JF - Developmental Pharmacology and Therapeutics
IS - 1
ER -